Trivant Custom Portfolio Group, LLC Bristol Myers Squibb CO Transaction History
Trivant Custom Portfolio Group, LLC
- $173 Billion
- Q3 2024
A detailed history of Trivant Custom Portfolio Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Trivant Custom Portfolio Group, LLC holds 200 shares of BMY stock, worth $11,682. This represents 0.01% of its overall portfolio holdings.
Number of Shares
200Holding current value
$11,682% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,494Shares Held
1.51BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA189MShares$11 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.27 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$5.34 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.55 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.56 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $124B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...